Phio Pharmaceuticals (PHIO) Revenue & Revenue Breakdown
Phio Pharmaceuticals Revenue Highlights
00
Phio Pharmaceuticals Revenue by Period
Phio Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | -100.00% |
2019-12-31 | $21.00K | -84.78% |
2018-12-31 | $138.00K | 820.00% |
2017-12-31 | $15.00K | -21.05% |
2016-12-31 | $19.00K | -44.12% |
2015-12-31 | $34.00K | -52.11% |
2014-12-31 | $71.00K | -82.21% |
2013-12-31 | $399.00K | 311.34% |
2012-12-31 | $97.00K | 100.00% |
2011-12-31 | - | - |
Phio Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $30.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | -100.00% |
2019-03-31 | $21.00K | 100.00% |
2018-12-31 | - | -100.00% |
2018-09-30 | $57.00K | -1.72% |
2018-06-30 | $58.00K | 152.17% |
2018-03-31 | $23.00K | 53.33% |
2017-12-31 | $15.00K | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | -100.00% |
2016-06-30 | $9.00K | -10.00% |
2016-03-31 | $10.00K | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | -100.00% |
2015-03-31 | $34.00K | 142.86% |
2014-12-31 | $14.00K | -12.50% |
2014-09-30 | $16.00K | 33.33% |
2014-06-30 | $12.00K | -58.62% |
2014-03-31 | $29.00K | - |
2013-12-31 | $29.00K | -68.48% |
2013-09-30 | $92.00K | -59.11% |
2013-06-30 | $225.00K | 324.53% |
2013-03-31 | $53.00K | 32.50% |
2012-12-31 | $40.00K | -29.82% |
2012-09-30 | $57.00K | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | - |
Phio Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
VECT | VectivBio | $27.34M | $676.00K |
SONN | Sonnet BioTherapeutics | $147.81K | - |
CWBR | CohBar | - | - |
AVRO | AVROBIO | - | - |
CNSP | CNS Pharmaceuticals | - | - |
ZURA | Zura Bio | - | - |
ELEV | Elevation Oncology | - | - |
ATNF | 180 Life Sciences | - | - |
PHIO | Phio Pharmaceuticals | - | - |
ZVSA | ZyVersa Therapeutics | - | - |
OCEA | Ocean Biomedical | - | - |
IMMX | Immix Biopharma | - | - |
EFTR | eFFECTOR Therapeutics | - | - |
CDIO | Cardio Diagnostics | - | $6.58K |